CAS 1009119-64-5 appears in our catalog under these names: Daclatasvir, Daclatasvir, >95% (HPLC), Daclatasvir/ 99.81% (existing batch purity), Daclatasvir 98%, Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, 98%, 98%. Offered by: GLPBio, TRC, TargetMol, Biosynth, Ambeed. Available pack sizes: 5mg, 100mg, 10mg, 50mg, 25mg, 500mg, 1000mg, 2000mg.
Daclatasvir is a member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C. It has a role as an antiviral drug and a nonstructural protein 5A inhibitor. It is a member of biphenyls, a carbamate ester, a member of imidazoles, a valine derivative and a carboxamide. It is a conjugate base of a daclatasvir(2+).
Source: ChEBI
| Molecular formula | C40H50N8O6 |
|---|---|
| Molecular weight | 738.9 g/mol |
| IUPAC name | methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| InChIKey | FKRSSPOQAMALKA-CUPIEXAXSA-N |
| SMILES | CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC |
Computed by PubChem (NCBI)